These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 3269249)

  • 1. Continuous cell lines as substrates for biologicals: report of a joint meeting of WHO, IABS (cell Culture Committee Subsection), and ESACT.
    Spier RE
    Mol Biother; 1988; 1(2):114-5. PubMed ID: 3269249
    [No Abstract]   [Full Text] [Related]  

  • 2. Proceedings of the Joint ESACT -- IABS meeting on the use of heteroploid and other cell substrates for the production of biologicals. Heidelberg (F.R. Germany) 18-22 May, 1981.
    Dev Biol Stand; 1981; 50():1-398. PubMed ID: 7341286
    [No Abstract]   [Full Text] [Related]  

  • 3. Status of WHO concerning continuous cell lines as substrates for the production of biologicals.
    Grachev V; Magrath D
    Dev Biol Stand; 1989; 70():215-9. PubMed ID: 2759349
    [No Abstract]   [Full Text] [Related]  

  • 4. Proceedings of the Joint ESACT/IABS Meeting on the production and exploitation of existing and new animal cell substrates. Gardone Riviera, Italy, 21-25 May 1984.
    Dev Biol Stand; 1985; 60():1-540. PubMed ID: 3899778
    [No Abstract]   [Full Text] [Related]  

  • 5. Acceptability of cell substrates for production of biologicals. Report of a WHO Study Group on Biologicals.
    World Health Organ Tech Rep Ser; 1987; 747():1-29. PubMed ID: 3107222
    [No Abstract]   [Full Text] [Related]  

  • 6. WHO Study Group on Biologicals: history, issues and goals of the meeting.
    Petricciani JC; Ada GL; Robbins FC
    Dev Biol Stand; 1987; 68():1-4. PubMed ID: 3691961
    [No Abstract]   [Full Text] [Related]  

  • 7. World Health Organization attitude concerning the use of continuous cell lines as substrates for production of human virus vaccines.
    Grachev VP
    Adv Biotechnol Processes; 1990; 14():37-67. PubMed ID: 2222837
    [No Abstract]   [Full Text] [Related]  

  • 8. WHO requirements for the use of animal cells as in vitro substrates for the production of biologicals (requirements for biological substances No 50).
    Dev Biol Stand; 1998; 93():141-71. PubMed ID: 9737395
    [No Abstract]   [Full Text] [Related]  

  • 9. History of cell substrates used for human biologicals.
    Hayflick L
    Dev Biol Stand; 1989; 70():11-26. PubMed ID: 2668070
    [No Abstract]   [Full Text] [Related]  

  • 10. Should continuous cell lines be used as substrates for biological products?
    Petricciani JC
    Dev Biol Stand; 1987; 66():3-12. PubMed ID: 3582759
    [No Abstract]   [Full Text] [Related]  

  • 11. WHO requirements for the use of animal cells as in vitro substrates for the production of biologicals: application to influenza vaccine production.
    Griffiths E
    Dev Biol Stand; 1999; 98():153-7; discussion 167. PubMed ID: 10494968
    [No Abstract]   [Full Text] [Related]  

  • 12. Meeting to develop the 2006-2010 Work Plan of the Global Jetwork of the WHO Collaborating Centres in Occupational Health, Johanesburg, South Africa, 16-17 September 2005.
    Tomaszunas S
    Int Marit Health; 2005; 56(1-4):193-4. PubMed ID: 16532600
    [No Abstract]   [Full Text] [Related]  

  • 13. WHO Expert Committee On Biological Standardization.
    World Health Organ Tech Rep Ser; 1998; 878():i-vi, 1-101. PubMed ID: 9731464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological standardization of human interferon beta: establishment of a replacement world health organization international biological standard for human glycosylated interferon beta.
    Meager A; Das RG
    J Immunol Methods; 2005 Nov; 306(1-2):1-15. PubMed ID: 16226271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An overview of animal cell substrates for biological products.
    Petricciani J; Sheets R
    Biologicals; 2008 Nov; 36(6):359-62. PubMed ID: 18674929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. WHO Expert Committee on biological standardization.
    World Health Organ Tech Rep Ser; 2007; (941):1-340, back cover. PubMed ID: 18314862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Symposium on Continuous Cell Lines as Substrates for Biologicals. Arlington, Virginia, USA (Washington, D.C.), May 26-29, 1988. Proceedings.
    Dev Biol Stand; 1989; 70():1-304. PubMed ID: 2759343
    [No Abstract]   [Full Text] [Related]  

  • 18. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. A progress report.
    Jaffe ES; Harris NL; Diebold J; Muller-Hermelink HK
    Am J Clin Pathol; 1999 Jan; 111(1 Suppl 1):S8-12. PubMed ID: 9894466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Report of an informal meeting about alternative methods for the potency control of the diphtheria and tetanus components in vaccines.
    Kreeftenberg JG
    Dev Biol Stand; 1986; 65():261-6. PubMed ID: 3493932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Psychiatric care and the society. Report on a conference of the World Health Organization].
    Häfner H
    Fortschr Med; 1972 Oct; 90(28):997-8. PubMed ID: 4658470
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.